Be Biotechnologies is a commercial-stage bio-pharmaceutical founded on cannabinoid and plant-based research, development, and Evidence-based aimed at transforming bio-pharma sciences knowledge into novel pharmaceutical drugs for animals and humans.

Our research and development teams work with various in-house and in collaboration with other researchers in North America, Europe and Latam to perform Evidence-based research to develop the most cost-efficient drug to provide patients with access to affordable and modern Plant-based treatments.

These cannabinoid-based drug candidates provide solutions for unmet medical needs in the areas of dermatology, chronic pain, and various neurological disorders. Our platform has resulted in 20+ commercial formulations and products, including cosmetics, wellness, and pharmaceutical, besides its APIs/RAWs Material distribution and consulting business.

Be Biotechnologies want to become the hub for microgravity plant science in space, using the ISS National Laboratory in partnership with NASA and Implementation Partners to create the opportunity to deepen our drug development knowledge.

#bionyc #biomadrid #wearebiotech #bebiotech

Instagram @bebiotechnologies